Characterization of the signal transduction pathways mediating morphine withdrawal-stimulated c-fos expression in hypothalamic nuclei

European Journal of Pharmacology

Volumn 430, Issue 1, 2001, Pages 59-68

  Martínez, Pedro J ^a   Laorden, M Luisa ^a   Cerezo, Manuela ^a   Martínez Piero, M Gloria ^a   Milanés, M Victoria ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

C fos; Ca2+ channel; Morphine withdrawal; Paraventricular nucleus; Protein kinase A; Protein kinase C; Supraoptic nucleus

Indexed keywords

CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALPHOSTIN C; CHELERYTHRINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; MORPHINE; N (2 GUANIDINOETHYL) 5 ISOQUINOLINESULFONAMIDE; NALOXONE; NIMODIPINE; PROTEIN C FOS; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARTICLE; CALCIUM TRANSPORT; CELL ACTIVATION; CONTROLLED STUDY; DRUG WITHDRAWAL; ENZYME ACTIVE SITE; ENZYME ACTIVITY; IMMUNOREACTIVITY; MALE; NEUROSECRETORY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SUPRAOPTIC NUCLEUS;

ANIMALS; ANTERIOR HYPOTHALAMIC NUCLEUS; CALCIUM; CALCIUM CHANNELS, L-TYPE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MORPHINE; NALOXONE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY-ADRENAL SYSTEM; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SUBSTANCE WITHDRAWAL SYNDROME; SUPRAOPTIC NUCLEUS;

EID: 0035955352     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01356-5     Document Type: Article

References (49)

1. Immediate early gene expression during morphine withdrawal
2. Structure-function of the cloned opiate receptors: Peptide and small molecule interactions
3. Genetic analysis of drug addiction: The role of cAMP response element binding protein
4. Opioid receptor-coupled second messengers systems
5. Precipitated morphine withdrawal stimulates multiple activator protein-1 signaling pathways in rat brain
6. Calcium-regulated protein kinase cascades and their transcription factor targets
7. Psychomotor stimulant- and opiate-induced c-fos mRNA expression patterns in the rat forebrain: Comparisons between acute drug treatment and a drug challenge in sensitized animals
8. Chronic administration of morphine alters immediate-early gene expression in the forebrain of post-dependent rats
9. Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal
10. Changes in hypothalamic paraventricular nucleus catecholaminergic activity after acute and chronic morphine administration
11. ++ release or protein kinase C activation significantly reduces the development of morphine dependence
12. Effects of intracerebroventricular clonidine on the hypothalamic noradrenaline and plasma corticosterone levels of opiate naïve rats and after naloxone-induced withdrawal
13. Identification of morphine- and cyclic AMP-regulated phosphoprotein (MARPPs) in the locus coeruleus and other regions of rat brain: Regulation by acute and chronic morphine
14. Pattern of c-fos mRNA induction in rat brain by acute morphine
15. 2+ in neuronal cells
16. Chelerythrine is a potent and specific inhibitor of protein kinase C
17. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C
18. The potential for isoenzyme-selective modulation of protein kinase C
19. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system
20. Effects of specific Mu and Kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat
21. Calphostin C (UCN), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C
22. Different mechanisms mediate development and expression of tolerance and dependence for peripheral μ-opioid antiniciception in rat
23. c-Fos as a transcription factor: A stressful (re)view from a functional map
24. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists. Correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus
25. 2-adrenoceptors
26. Corticotrophin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat
27. Participation of noradrenergic pathways in the expression of opiate withdrawal: Biochemical and pharmacological evidence
28. Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine
29. Plasma β-endorphin and cortisol levels in morphine-tolerant rats and in naloxone-induced withdrawal
30. Alterations in corticotropin-releasing factor and vasopressin content in rat brain during morphine withdrawal. Correlation with hypothalamic noradrenergic activity and pituitary-adrenal response
31. Stimulus-transcription coupling in the nervous system: Involvement of the inducible proto-oncogenes fos and jun
32. Influence of chronic morphine treatment on protein kinase C activity: Comparison with butorphanol and implication for opioid tolerance
33. A protein kinase inhibitor, H-7, inhibits the development of tolerance to opioid antiniciception
34. Molecular mechanism of drug addiction
35. Molecular and cellular basis of addiction
36. Induction of chronic fos-related antigens in rat brain by chronic morphine administration
37. Effects of opioids on the hypothalamo-pituitary-adrenal axis
38. Opioid enhancement of calcium oscillations and burst events involving NMDA receptors and L-type calcium channels in cultured hippocampal neurons
39. Opioid withdrawal activates MAP kinase in locus coeruleus neurons in morphine-dependent rats in vivo
40. The stimulatory effects of opioids and their possible role in the development of tolerance
41. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the rat
42. Structural framework for the protein kinase family
43. Possible involvement of proteinkinases in physical dependence on opioids: Studies using protein kinase inhibitors, H-7 and H-8
44. Structural organization of the 5′ flanking region of the human corticotropin releasing hormone gene
45. Calcium signalling and gene expression
46. Neurochemical activity of noradrenergic neurons and pituitary-adrenal response after naloxone-induced withdrawal: The role of calcium channels